Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

被引:471
作者
Kojouri, K
Vesely, SK
Terrell, DR
George, JN
机构
[1] OU Med Ctr, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Hematol Oncol Sect, Oklahoma City, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA
关键词
D O I
10.1182/blood-2004-03-1168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Splenectomy has been a standard treatment for adult patients with idiopathic thrombocytopenic purpura (ITP) for more than 50 years. However, the durability of responses, the ability to predict who will respond, and the frequency of surgical complications with splenectomy all remain uncertain. To better interpret current knowledge we systematically identified and reviewed all 135 case series, 1966 to 2004, that described 15 or more consecutive patients who had splenectomy for ITP and that had data for 1 of these 3 outcomes. Complete response was defined as a normal platelet count following splenectomy and for the duration of follow-up with no additional treatment. Forty-seven case series reported complete response in 1731 (66%) of 2623 adult patients with follow-up for 1 to 153 months; complete response rates did not correlate with duration of follow-up (r = -0.103, P =.49). None of 12 preoperative characteristics that have been reported consistently predicted response to splenectomy. Mortality was 1.0% (48 of 4955 patients) with laparotomy and 0.2% (3 of 1301 patients) with laparoscopy. Complication rates were 12.9% (318 of 2465) with laparotomy and 9.6% (88 of 921 patients) with laparoscopic splenectomy. Although the risk of surgery is an important consideration, splenectomy provides a high frequency of durable responses for adult patients with ITP. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2623 / 2634
页数:12
相关论文
共 148 条
[1]  
AKSNES J, 1995, EUR J SURG, V161, P253
[2]   SPLENECTOMY FOR PRIMARY AND RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) - CURRENT CRITERIA FOR PATIENT SELECTION AND RESULTS [J].
AKWARI, OE ;
ITANI, KMF ;
COLEMAN, RE ;
ROSSE, WF .
ANNALS OF SURGERY, 1987, 206 (04) :529-541
[3]   Idiopathic thrombocytopenic purpura -: A retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol [J].
Andrès, E ;
Zimmer, J ;
Noel, E ;
Kaltenbach, G ;
Koumarianou, A ;
Maloisel, F .
DRUGS & AGING, 2003, 20 (11) :841-846
[4]   Short-course corticosteroid-induced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura [J].
Apostolidis, J ;
Tsandekidi, M ;
Kousiafes, D ;
Pagoni, M ;
Mitsouli, C ;
Karmiris, T ;
Bakiri, M ;
Karakasis, D ;
Harhalakis, N ;
Nikiforakis, E .
BLOOD, 2001, 98 (09) :2875-2877
[5]   Steep learning curve of laparoscopic splenectomy [J].
Bagdasarian, RW ;
Bolton, JS ;
Bowen, JC ;
Fuhrman, GM ;
Richardson, WS .
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES-PART A, 2000, 10 (06) :319-323
[6]   Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura [J].
Bell, WR .
SEMINARS IN HEMATOLOGY, 2000, 37 (01) :22-25
[7]  
BENYEHUDA D, 1994, ACTA HAEMATOL-BASEL, V91, P1
[8]  
Bohner H, 1997, LANGENBECK ARCH CHIR, V382, P79
[9]   Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines [J].
BoltonMaggs, PHB ;
Moon, I .
LANCET, 1997, 350 (9078) :620-623
[10]   Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis [J].
Bourgeois, E ;
Caulier, MT ;
Delarozee, C ;
Brouillard, M ;
Bauters, F ;
Fenaux, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) :1079-1088